PurMinds NeuroLabs
Advancing Psychoactive Neuromedicine
TM
PurMinds NeuroLabs was granted a Controlled Drugs and Substances License by Health Canada in 2020. This license created a unique environment for pioneering research and development, leading to a proprietary suite of intellectual property centered on psychedelic compounds for neurological disorders. This foundation continues to drive our innovative approach to address some of the most complex challenges in brain health. ​
​
TM
Proprietary Psilocybin Formulations
Our formulation team has developed a portfolio of pharma-grade botanical psilocybin innovations, including:
​
· Purified psilocybin isolates derived from botanical sources
· Psilocybin formulations with varying tryptamine profiles, designed to harness the entourage effect
These advancements establish PurMinds as a leader in translating psychedelic science into therapeutic solutions.
TM
Global Collaboration for Impact
We are actively building partnerships with hospitals, research institutions and industry leaders worldwide to accelerate the development of safe, effective treatments for neurological and mental health disorders.
TM
TM